's Information

Jung-Min Ahn , MD

Country Korea (Republic of)
Specialty Interventional Cardiologist
  1. TAVR for Bicuspid AV: What's Different?
  2. VARIANT-ICD Trial: ICD vs. Medical Therapy Alone in Variant Angina With Aborted SCD
  3. FATE-MAIN Trial: FFR- vs. Angiography-guided Left Main PCI
  4. PREVENT Trial: Preventive PCI or Medical Therapy Alone for Vulnerable Atherosclerotic Coronary Plaque
  5. 15 Years History of TAVR in Asan Medical Center: Minimalist Intuitive Simple Approaches
  6. Bicuspid TAVR: All the Technical Issues and Data From Asan Medical Center
  7. Synergetic Approach for Discordant Lesions Between FFR and Non-Hyperemic Indexes
  8. The Fate of Deferred Lesions; Insight From the IRIS-FFR Registry
  9. Rule of 5-6-7-8 for Bifurcation PCI: It Is Time to Change in 2024
  10. Left Main AMI with Cardiogenic Shock, How to Rescue?
  11. Choosing Wisely: FFR vs. Anatomy Dilemma in LM PCI and Introduction to FATE-MAIN Trial
  12. Precision in Stent Sizing: Insights from Imaging-Guided LM PCI
  13. TAVR for Bicuspid AV: What’s Different?
  14. Synergetic Approach for Discordant Lesions Between FFR and Hyperemia Free Indexes
  15. ASSURE-DES Trial
  16. 10-Year Extended Follow-up of BEST Trial
  17. Defining Lesion Severity (by Angiography, Physiology & IVUS)
  18. Not to Treat
  19. Optimal MSA for LM Crush Technique: New Criteria Any Difference in Any 2 Stent Technique?
  20. TAVR Techniques in Bicuspid Anatomy – Valve Selection, Sizing, and Positioning
  21. How to Optimize 1st Valve Choice Matter for Future
  22. How Can We Treat Patients with Concomitant Coronary Artery Disease?
  23. Low Penetration of FFR (1A Class) in Real Practice; Why and How to Overcome?
  24. Case 4. CTO
  25. CTO Revascularization 2022: Guidelines and Concept Change
  26. Physiologic Approach For Non-LM Bifurcation Disease
  27. Unmet Need for FFR in LM PCI
  28. Minimalist TAVI : Achieving Great TAVI Efficiency and Optimal Patient Outcome
  29. 타비 시술을 위한 CT 평가
  30. TAVR for Bicuspid Valve: Practical Tips and Tricks for Optimal Sizing and Positioning
  31. FFR is a Routine Cath Lab Procedure
  32. FFR, It\'s Standard
  33. The Basics of Coronary Physiology Measurement: FFR, iFR and other NHPRs
  34. Updated Imaging/Physiology-Guided PCI Tuning 2021
  35. Under Pressure: Optimal Post-Dilation Strategy
  36. Difficult Wiring, Tips and Tricks
  37. TAVR for Bicuspid AS: Optimal Sizing & Valve Selection
  38. Imaging-guided PSP for Optimizing PCI
  39. How to Treat Tandem Lesion Under Physiology-Guidance
  40. Guide Extension Catheters: Strong Support from Mother-Child Relationship
  41. Post TAVR Coronary Access with Evolut System
  42. Self-Expandable Evolut R & PRO Valve
  43. TAVR for Bicuspid AV: Tips and Tricks
  44. Bifurcation PCI: Contemporary Practical Approach
  45. The Role of Debulking Atherectomy for Calcific In-stent Restenosis
  46. Prognosis of Discordant Lesion Between FFR and Hyperemia Free Indexes
  47. [Case-based Debate: Intracoronary Imaging Modalities for PCI Guidance] IVUS Is Better!
  48. Clinically Relevant PeriProcedural MI: Practical and Clinical Trial Aspect
  49. Case 1: Unexpanded ISR - Challenging and Optimal Treatment
  50. How Do I Implement?: FFR and Various Non-hyperemic Diastolic Index
  51. Current Status of Balloon-Expandable TAVR in Korea
  52. OAC in TAVR: FAILED GALILEO - NOAC Don\'t Work or Other Options?
  53. TAVR for Bicuspid AV: Tips and Tricks
  54. Synergetic Approach for Discordant Lesions Between FFR and Hyperemia Free Indexes
  55. Guide Extension Catheters: A Strong Support from a Parent-Child Relationship
  56. Expert Case Review: Complex PCI for Severe Calcified Coronary Disease
  57. Expert Case Review: Complex Bifurcation PCI
  58. Impact of Renal Function on Stroke or Systemic Embolism Following TAVR
  59. TAVR for Bicuspid Valve: Clinical Outcome and Technical Considerations
  60. TAVR: Bicuspid, Severe Calcium, and Low Lying Left Main
  61. TAVR in Bicuspid Aortic Stenosis with Severe Calcification: Case Reviews and Tips-and-Tricks
  62. How About Integrated Use of Resting Pd/Pa and FFR?
  63. Distal Left Main Bifurcation PCI: Concept Is More Important.
  64. [Case #2: Transcatheter Aortic Valve Implantation in a Patient with Type B Aortic Dissection] Part 2. How Would I Treat?
  65. FFR as the Gold Standard Index!
  66. Five-Year Outcomes of Routine FFR Use in Clinical Practice: Data from ASAN PCI Registry
  67. The Benefit of Complete Revascularization in Complex Coronary Artery Disease
  68. Asian Pacific TAVR Registry
  69. [Taped Case] TAVR with Evolut R
  70. Bicuspid AS: Future Perspectives of TAVR
  71. Integrated Use of FFR and IVUS for LM PCI
  72. Bicuspid TAVR Registry and TRANSIT Trial: TAVI Experience in AMC
  73. Bicuspid and Valve-in-Valve; How Different?
  74. Clinical Outcome of DEFER
  75. Left Main and MVD PCI: Imaging and Functional Guidance
  76. Utility of Intravascular Imaging for Resolving Issues During PCI
  77. Long Lesion and Tandem Lesion
  78. Bicuspid TAVR Registry
  79. AP TAVR Registry
  80. Current Status of TAVR: High/Intermediate and Lower Risk
  81. Clinical Impact of Routine FFR Measurement
  82. Tandem
  83. Prognostic Value of FFR: Insight from IRIS-FFR Registry
  84. Practical Aspect of IMR in AMI and Stable Angina
  85. Elderly Population
  86. LM PCI 2016: Integrated Approach Using IVUS, FFR and New Imaging Modality
  87. [Review in 2015] Physiology
  88. Tandem Lesion Evaluation
  89. Integrated Use of IVUS and FFR in Real Practice
  90. Readmission After PCI or CABG
  91. Left Main
  92. Final Answer RESTORE
  93. Comparative Outcomes of Various DES from IRIS-MAIN Registry and PRECOMBAT Series
  94. Case Presentation 4: Medically Stabilized Type A Aortic Dissection After TAVI
  95. Randomzed Trial of Stents Versus Bypass Surgery for Left Main Coronary Artery Disease: Five-Year Outcomes of the PRECOMBAT Study
  96. Preliminary Data from IRIS FFR Registry
  97. Complex Lesions, Left Main, Bifurcations, Tandem, and More
  98. Left Main PCI
  99. Understanding About Visual-Functional Mismatching
  100. TAVI for Bicuspid Valve Stenosis
  101. FFR-guided PCI in Routine Practice: Learn from AMC Experiences
  102. Is There a Generation Gap of DES: Results of PRECOMBAT Study Series
  103. Clinical Implementation of FFR
  104. Case-based Review: Incidence and Treatment of LM ISR
  105. LM & Tandem Lesion
  106. VH IVUS: Native Plaque and Neointima
  107. Clinical Evidence of Neoatherosclerosis: ISR and Late Stent Thrombosis
  108. LM PCI
  109. IRIS-ELEMENT Data Review
  110. Cross and Perfect: 2013 Update
  111. Anatomical - Functional Stenosis: How Much Discordant?
  112. Case Presentation: Functional Angioplasty
  113. Impact of Functional Angioplasty on Clinical Outcomes of PCI
  114. Novice's Trial of Complex LM PCI
  115. New-generation DES for Long Lesions: From a Large-scale Cohort Regis
  116. FFR Utilization in LM PCI
  117. Promus Element Clinical Program in Asan Medical Center
  118. FFR-guided PCI in Tandem Lesion
  119. Two Cases with Coronary Thromboembolism
  120. Does the Timing of IABP Matter?
Conference Slides
Category